Form 4 for GILD Gilead Sciences
Accepted 2026-03-12 00:00:00 ET · period of report 2026-03-10 · accession 0001739515-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-12 | 2026-03-10 | GILD | Berger Dietmar | Chief Medical Off | M - OptEx | — | +2,133 | 20.0K | +12% | — |
| D | 2026-03-12 | 2026-03-10 | GILD | Berger Dietmar | Chief Medical Off | F - Tax | $148.56 | -1,063 | 19.0K | -5% | -$157.9K |
| D | 2026-03-12 | 2026-03-10 | GILD | Berger Dietmar | Chief Medical Off | M - OptEx | — | -2,133 | 39.0K | -5% | — |
| DM | 2026-03-12 | 2026-03-10 | GILD | Berger Dietmar | Chief Medical Off | A - Grant | $0.00 | +39.9K | 47.5K | +527% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-10 | M | A | 2,133 | — | 20,045 | D | — | — | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| 2 | Common | Common Stock | 2026-03-10 | F | D | 1,063 | $148.56 | 18,982 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2026-03-10 | M | D | 2,133 | — | 39,046 | D | — · — to — | 2,133 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested. |
| 4 | Derivative | Non-qualified Stock Option (Right to Buy) | 2026-03-10 | A | A | 31,475 | $0.00 | 31,475 | D | $148.56 · — to 2036-03-10 | 31,475 Common Stock | (F3) The stock options have a four-year vesting schedule. 25% of the options vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |
| 5 | Derivative | Restricted Stock Unit | 2026-03-10 | A | A | 8,415 | — | 47,461 | D | — · — to — | 8,415 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested. |